Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

The Tel Aviv Stock Exchange (TASE) update about the Sale of the Arrangement Shares and Receipt of the Excess Consideration in Respect Thereof


News provided by

The Tel Aviv Stock Exchange Ltd.

05 Jul, 2023, 19:09 IDT

Share this article

Share toX

Share this article

Share toX

TEL AVIV, Israel, July 5, 2023 /PRNewswire/ -- Further to the stated in section 1.3.1 of the "Description of the Company's Business" chapter, which is included in the Company's periodic report for 2022, published on March 28, 2023 (reference no.: 2023-01-033528) (hereafter: "the Periodic Report"), The Tel Aviv Stock Exchange Ltd (TASE: TASE) ("the Company") hereby updates as follows:

In the period subsequent to the publication of the Periodic Report until July 4, 2023, following the sale of 703,000 ordinary shares of the Company that are Arrangement Shares (as defined in the Periodic Report) by various shareholders of the Company, the Company has received an amount of approximately NIS 10 million, representing the excess consideration in respect thereof. It should be noted that the selling shareholders, as above, are three banking corporations that are TASE members, which had held shares of the Company on the date of approval of the TASE restructuring arrangement, as described in section 1.3.1 of the Periodic Report.

For additional information regarding the calculation method of the excess consideration and the adjustment to dividends that have been or that will be distributed, see section 1.3.1 of the Periodic Report. The information that is provided in the Periodic Report is included herein by way of reference.

Click here for the link to the full report.

Contact:
Orna Goren
Head of Communication and Public Relations Unit
Tel: +972 76 8160405
[email protected]

SOURCE The Tel Aviv Stock Exchange Ltd.

Modal title

Also from this source

TASE Reports its Financial Results for Q3 2025

The Tel-Aviv Stock Exchange (TASE: TASE) today announced its financial results for the third quarter, ended on September 30, 2025. Trends and...

TASE Announces an Historic Milestone -The Largest-Ever Equity Indices Update Kicks Off

Today, November 6, 2025, during the closing auction, The Tel Aviv Stock Exchange (TASE) (TASE: TASE) will execute its largest-ever equity indices...

More Releases From This Source

Explore

Banking & Financial Services

Banking & Financial Services

Publishing & Information Services

Publishing & Information Services

Accounting News & Issues

Accounting News & Issues

Financing Agreements

Financing Agreements

News Releases in Similar Topics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.